Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Schulz Eduard |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Schulz, E; Posch, F; Friedrich, K; Neumeister, P; Prochazka, K
Comparison of outcomes after DA-EPOCH-R or GMALL high-intensity therapy for frontline treatment of Burkitt lymphoma: A retrospective cohort
Oncol Res Treat. 2024; 47(Suppl2):307--Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 11-14, 2024; Basel, Switzerland.
[Poster]
FullText
Schloffer, L; Neumeister, P; Greinix, HT; Hatzl, S; Schulz, E
Outcome of Adult Patients with Acute
Lymphoblastic Leukemia Treated in Graz Between
2001 to 2021
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. memo. 2023; 16(Suppl1):S1--Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 30 - APR 1, 2023; Innsbruck, Austria.
[Poster]
FullText
Scholz, L; Posch, F; Schulz, E; Gornicec, M; Rosenkranz, AR; Schilcher, G; Krause, R; Hatzl, S
Ruxolitinib, Intravenous Immunoglobulin and High-Dose Corticosteroids in the Management of Critically Ill Adult Patients with Hemophagocytic Lymphohistiocytosis
41. Wiener Intensivmedizinische Tage ; FEB 15-18, 2023; Vienna, AUSTRIA. 2023.
[Oral Communication]
Scholz, L; Posch, F; Schulz, E; Gornicec, M; Rosenkranz, AR; Schilcher, G; Reisinger, A; Krause, R; Hatzl, S
Ruxolitinib, intravenous immunoglobulin and high-dose corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis
MED KLIN-INTENSIVMED. 2023; 118(5):
[Oral Communication]
Web of Science
Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Krassnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P
Pathogen detection by metagenomic next-generation sequencing during neutropenic fever in patients with haematological malignancies
BRIT J HAEMATOL. 2023; 201: 21-22.-63rd Annual Scientific Meeting of the British-Society-for-Haematology; APR 23-25, 2023; Birmingham, ENGLAND.
[Poster]
Web of Science
Schulz, E; Holtzman, NG; Ostojic, A; Pirsl, F; Steinberg, SM; Curtis, LM; Shaffer, BC; Heller, T; Carpenter, A; Beshensky, D; Rubin, JS; Gress, RE; Pavletic, SZ
Phase 2 Study of Single High-Dose Palifermin for Graft-Versus-Host Disease Prevention after Matched Unrelated Donor Transplantation.
Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy. 2023; 29(2):S258-S259.-Tandem Meetings of ASTCT and CIBMTR; 15 February 2023 - 19 February 2023; Orlando, FL, USA.
[Poster]
FullText
Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
ÖGR Jahrestagung 2022; NOV 3-5, 2022; Vienna, AUSTRIA. 2022.
[Poster]
Schulz, E; Pirsl, F; Beshensky, D; Holtzman, NG; Steinberg, SM; Pavletic, SZ
RDW Is an Independent Prognostic Biomarker in Patients with Chronic Graft-Versus-Host-Disease.
Blood . 2022; 140(S1):10554-10556.-64th ASH Annual Meeting and Exposition; Dec 10-13, 2022; New Orleans, LA, USA.
[Poster]
FullText
Hatzl, M; Kalmar, P; Posch, F; Riedl, JM; Beham-Schmid, C; Prochazka, K; Greinix, H; Schwarz, T; Gstettner, G; Neumeister, P; Schulz, E
BASELINE TOTAL METABOLIC TUMOR VOLUME >220CM³ AND DEAUVILLE 5-POINT SCALE OF ≥4 AFTER FOUR CYCLES OF R-CHOP ARE STRONGLY ASSOCIATED WITH INFERIOR PROGRESSION FREE SURVIVAL IN PATIENTS WITH DLBCL
EHA Library. Hatzl S. 06/09/21; 325281; EP521.. 2021; -26th Congress of the European Hematology Association; JUNE 9-17,2021; virtual .
[Poster]
FullText
Schulz, E
COVID-19 in allogeneic stem cell recipients
Jahrestagung der DGHO, OeGHO, SGMO, SGH 2021; OCT 1-4, 2021; Berlin. 2021.
[Oral Communication]
Schulz, E
Akute lymphoblastische Leukämie und Burkitt-Lymphom
Wissenschaftliche Highlights ASH 2020; 20.01.2021; Graz. 2021.
[Oral Communication]
Schulz, E; Grumaz, S; Huber-Kraßnitzer, B; Deutsch, A; Krause, R; Neumeister, P;
Pathogen detection by metagenomic next-generation sequencing during neutropenic fever in patients with haematological malignancies
31st European Congress of Clinical Microbiology & Infectious Diseases; 9 - 12 July 2021; Vienna, AUSTRIA. 2021.
[Poster]
FullText
Schulz, E
Akute lymphatische Leukämie
Wissenschaftliche Highlights ASH 2019; 23.01.2020; Graz. 2020.
[Oral Communication]
Gornicec, M; Reinisch, A; Hatzl, S; Schilcher, G; Wölfler, A; Schulz, E
Sustained complete remission with Ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis: a case report
Oncol Res Treat 2019;42(suppl 4):1-336. 2019; -Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie; OCT 11-14, 2019; Berlin, GERMANY.
[Poster]
FullText
Schulz, E
Akute lymphatische Leukämie und Non-Hodgkin-Lymphome“
Wissenschaftliche Highlights ASH 2018; 31.01.2019; Graz. 2019.
[Oral Communication]
Schulz, E
Akute lymphatische Leukämie und Non-Hodgkin-Lymphome“
Wissenschaftliche Highlights ASH 2017; 18.01.2018; Graz. 2018.
[Oral Communication]
Neumeister, P; Spindelboeck, W; Zinke-Cerwenka, W; Schulz, E; Hoegenauer, C; Sill, H; Gorkiewicz, G; Kump, P; Greinix, H
Successful treatment of steroid-refractory acute gastrointestinal graft-versus-host-disease by fecal microbiota transplantation
BONE MARROW TRANSPL. 2017; 52: S232-S232.
Web of Science
Schulz, E
Akute lymphatische Leukämie und Non-Hodgkin-Lymphome
Wissenschaftliche Highlights ASH 2016; 26.01.2017; Graz. 2017.
[Oral Communication]
Lal, R; Lind, K; Kashofer, K; Heitzer, E; Ulz, P; Troppmair, J; Hofer, S; Schulz, E; Mathre, K; Wölfler, A; Zebisch, A; Sill, H
TP53 mutations in acute myeloid leukemia affect pre-leukemic stem cells
memo - Magazine of European Medical Oncology . 2016; 0(1):19-20.-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; MAR 17-19, 2016; Vienna, AUSTRIA.
[Poster]
Olipitz, W; Lind, K; Monsberger, N; Katschnig, A; Mangerich, A; Rankl, J; Hofer, S; Mueller, M; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Woelfler, A; Zebisch, A; Sill, H
IMPAIRED BASE EXCISION REPAIR GLYCOSYLASE/AP ENDONUCLEASE ACTIVITY CONTRIBUTES TO CYTARABINE RESISTANCE IN ACUTE MYELOID LEUKEMIA
HAEMATOLOGICA. 2016; 101: 211-212.
[Poster]
Web of Science
Schulz, E; Lind, K; Renner, W; Petersen, BS; Dill, C; Hofer, S; Lal, R; Quehenberger, F; Stolzel, F; Sill, H
THE HOMOZYGOUS TP53 P72R SNP IS ASSOCIATED WITH NON-FAVORABLE CYTOGENETIC RISK GROUPS IN ACUTE MYELOID LEUKEMIA
HAEMATOLOGICA. 2016; 101: 383-383.
[Poster]
Web of Science
Zebisch, A; Schulz, E; Hatzl, S; Grosso, M; Lombardo, B; Acierno, G; Sill, H; Iolascon, A
Epsilon-gamma-delta-beta° thalassemia Austrian I: identification of a novel hemoglobinopathy.
memo-magazine of european medical oncology; 2015 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology.. 2015; 8(1):-Annual Meeting of the Austrian Society of Haematology and Medical Oncology; APR 23-25, 2015; Salzburg, AUSTRIA.
[Poster]
Kuepper, MK; Wolf, O; Huber-Krassnitzer, B; Wieser, R; Pichler, M; Scheideler, M; Woelfler, A; Sill, H; Zebisch, A
Overexpression of miR-23a, miR-24 and miR-15a in acute myeloid leukemia with loss of the RAF kinase inhibitor protein.
memo-magazine of european medical oncology 2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology. 2014; 7(1):-Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA.
[Oral Communication]
Lind, K; Olipitz, W; Monsberger, N; Katschnig, A; Hofer, S; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Wölfler, A; Zebisch, A; Sill, H
Defizienz der Basen-Exzisions-Reparatur (BER) bei akuter myeloischer Leukämie (AML).
memo-magazine of european medical oncology
2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology. 2014; 7(1):-Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA.
[Poster]
Olipitz, W; Lind, K; Monsberger, N; Katschnig, A; Mangerich, A; Hofer, S; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Woelfler, A; Zebisch, A; Sill, H
Base Excision Repair Glycosylase Activity Is Impaired in a Subgroup of Acute Myeloid Leukemia Resulting in Increased Levels of Oxidative Base Lesions
BLOOD. 2014; 124(21):-56th Annual Meeting of the American-Society-of-Hematology; DEC 06-09, 2014; San Francisco, CA.
[Poster]
Web of Science
Olipitz, W; Lind, K; Monsberger, N; Katschnig, A; Mangerich, A; Hofer, S; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Wölfler, A; Zebisch, A; Sill, H
Base excision repair glycosylase activity is impaired in a subgroup of acute myeloid leukemia resulting in increased levels of oxidative base lesions
Oncol Res Treat. 2014; 37(S5):49-49.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 )
[Poster]
Web of Science
Schulz, E
Charakterisierung einer genetischen Prädisposition zu familiärem, kolorektalem Karzinom Typ X-Syndrom
Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA. 2014.
[Oral Communication]
Schulz, E; Kashofer, K; Mhatre, KN; Höfler, G; Sill, H
SELECTION OF A PRE-EXISTING TP53 MUTATED CLONE IN THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Haematologica. 2014; 99(S1):15-15.-19th Congress of the European Hematology Association; JUNE 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
FullText
Schulz, E; Kashofer, K; Mhatre, KN; Höfler, G; Sill H
Selektion eines prä-existenten TP53 mutierten Klons durch zytotoxische Behandlung bei einem Patienten mit Therapie-assoziierter AML (t-AML)
memo-Magazine of European Medical Oncology, Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2014; 7(1):-Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA.
[Poster]
FullText
Schulz, E; Klampfl, P; Holzapfel, S; Janecke, AR; Ulz, P; Renner, W; Kashofer, K; Najima, S; Leitner, A; Zebisch, A; Wölfler, A; Hofer, S; Gerger, A; Lax, S; Beham-Schmid, C; Steinke, V; Geigl, JB; Höfler, G; Speicher, MR; Boland, CR; Kumanogoh, A; Sill, H
Germline variants in the semaphorin SEMA4A confer susceptibility to familial colorectal cancer type X
Oncol Res Treat. 2014; 37(S5):105-105.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14, 2014; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 )
[Oral Communication]
Web of Science
Wolf, O; Schulz, E; Theiler, G; Troppmair, J; Kolch, W; Haller, M; Woelfler, A; Sill, H; Zebisch, A
RAF kinase inhibitor protein inhibits 1,25-dihydroxyvitamin D3 induced myelomonocytic differentiation of HL-60 acute myeloid leukemia cells.
memo-magazine of european medical oncology
2014 Proceedings of the Annual Meeting of the Austrian Society for Haematology and Medical Oncology. 2014; 7(1):-Annual Meeting of the Austrian Society for Haematology and Medical Oncology; APR 10-12, 2014; Innsbruck, AUSTRIA.
[Poster]
Schulz, E; Valentin, A; Ulz, P; Beham-Schmid, C; Lind, K; Rupp, V; Lackner, H; Wolfler, A; Zebisch, A; Olipitz, W; Geigl, JB; Berghold, A; Speicher, MR; Sill, H
Germ-line mutations in cancer predisposing genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy-related myeloid neoplasms.
ONKOLOGIE. Onkologie. 2012; 35: 117-117.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 19-23, 2012; Stuttgart, GERMANY.
[Poster]
Web of Science
Schulz E, Rohn A, Hiden K, Wölfler A, Beham-Schmid C, Guelly C, Lackner H, Geigl J, Speicher M, Sill H
Germ-line mutations in the DNA damage response and repair genes BRCA1, BARD1 and TP53 in patients with therapy-related myeloid neoplasms.
Haematologica 2011. 2011; 96(S2):25--Annual Meeting of the European Hematology Association; JUNE 2011; London, UK.
[Poster]
Schulz, E; Rohn, A; Lind, K; Woelfler, A; Beham-Schmid, C; Guelly, C; Lackner, H; Geigl, J; Speicher, M; Sill, H
Keimbahnmutationen in den DNA-Reparatur und Apoptose-induzierenden Genen BRCA1, BARD1 und TP53 bei Patienten mit Therapie-assoziierten myeloischen Neoplasien.
OeGHO Frühjahrstagung (Young Investigator Meeting); MAY, 5-7, 2011; Pörtschach, AUSTRIA. 2011.
[Oral Communication]